Inactivation of metronidazole by aerobic organisms.

Suppr

超能文献

作者信息

Edwards D I, Thompson E J, Tomusange J, Shanson D

出版信息

J Antimicrob Chemother. 1979 May;5(3):315-6. doi: 10.1093/jac/5.3.315.

DOI:10.1093/jac/5.3.315

PMID:113378

Abstract

摘要

相似文献

Inactivation of metronidazole by aerobic organisms.

J Antimicrob Chemother. 1979 May;5(3):315-6. doi: 10.1093/jac/5.3.315.

The reductive metabolism of metronidazole and ronidazole by aerobic liver microsomes.需氧肝微粒体对甲硝唑和罗硝唑的还原代谢。

Mol Pharmacol. 1980 Mar;17(2):239-44.

Comparing the reduction of nitroimidazoles in bacteria and mammalian tissues and relating it to biological activity.比较细菌和哺乳动物组织中硝基咪唑的还原情况，并将其与生物活性相关联。

Biochem Pharmacol. 1986 Jan 1;35(1):43-51. doi: 10.1016/0006-2952(86)90553-8.

Inactivation of metronidazole by Enterococcus faecalis.

J Antimicrob Chemother. 1991 Jan;27(1):63-70. doi: 10.1093/jac/27.1.63.

The pharmacokinetics of metronidazole and tinidazole in patients with mixed aerobic--anaerobic infections.甲硝唑和替硝唑在需氧-厌氧混合感染患者中的药代动力学。

J Antimicrob Chemother. 1982 Aug;10 Suppl A:59-64. doi: 10.1093/jac/10.suppl_a.59.

Nitroimidazoles in the canine prostate, vagina, and urethra.犬前列腺、阴道及尿道中的硝基咪唑类药物。

Prostate. 1981;2(1):71-8. doi: 10.1002/pros.2990020107.

Phagocytosis and killing of bacteria in aerobic and anaerobic conditions.

J Med Microbiol. 1981 Nov;14(4):391-9. doi: 10.1099/00222615-14-4-391.

Reductive activation of nitroimidazoles in anaerobic microorganisms.厌氧微生物中硝基咪唑的还原活化作用。

Biochem Pharmacol. 1986 Jan 1;35(1):37-41. doi: 10.1016/0006-2952(86)90552-6.

[Metronidazole-inactivating activity of cell-free extracts of Streptococcus faecalis].粪链球菌无细胞提取物的甲硝唑失活活性

Nihon Saikingaku Zasshi. 1985 Mar;40(2):501-9. doi: 10.3412/jsb.40.501.

Metronidazole (flagyl) and misonidazole (Ro-07-0582): reduction by facultative anaerobes and cytotoxic action on hypoxic bacteria and mammalian cells in vivo.甲硝唑（灭滴灵）和米索硝唑（Ro-07-0582）：兼性厌氧菌的还原作用以及对体内缺氧细菌和哺乳动物细胞的细胞毒性作用

Br J Cancer Suppl. 1978 Jun;3:132-5.

引用本文的文献

Antimicrobial Resistance in Curable Sexually Transmitted Infections.可治愈性传播感染中的抗菌药物耐药性

Curr HIV/AIDS Rep. 2025 Jan 25;22(1):14. doi: 10.1007/s11904-025-00722-7.

Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.定量建模预测了预处理微生物组组成与细菌性阴道病中甲硝唑疗效之间的机制联系。

Nat Commun. 2020 Dec 1;11(1):6147. doi: 10.1038/s41467-020-19880-w.

A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in .关于 5-硝基咪唑类耐药机制的文献的系统综述。

Parasitology. 2020 Nov;147(13):1383-1391. doi: 10.1017/S0031182020001237. Epub 2020 Jul 30.

Recurrent Clostridium difficile infection: From colonization to cure.复发性艰难梭菌感染：从定植到治愈

Anaerobe. 2015 Aug;34:59-73. doi: 10.1016/j.anaerobe.2015.04.012. Epub 2015 Apr 27.

Trichomoniasis as seen in a chronic vaginitis clinic.慢性阴道炎门诊所见的滴虫病。

Infect Dis Obstet Gynecol. 1996;4(2):77-84. doi: 10.1155/S1064744996000178.

Symbiosis of Mycoplasma hominis in Trichomonas vaginalis may link metronidazole resistance in vitro.人型支原体与阴道毛滴虫的共生可能与体外甲硝唑耐药性有关。

Parasitol Res. 2006 Dec;100(1):123-30. doi: 10.1007/s00436-006-0215-y. Epub 2006 Jul 18.

Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.耐甲硝唑阴道毛滴虫引起的感染的治疗。

Clin Microbiol Rev. 2004 Oct;17(4):783-93, table of contents. doi: 10.1128/CMR.17.4.783-793.2004.

Clinical and microbiological aspects of Trichomonas vaginalis.阴道毛滴虫的临床和微生物学方面

Clin Microbiol Rev. 1998 Apr;11(2):300-17. doi: 10.1128/CMR.11.2.300.

In vitro susceptibility of Trichomonas vaginalis strains to metronidazole--a Nigerian experience.阴道毛滴虫菌株对甲硝唑的体外敏感性——尼日利亚的经验

Genitourin Med. 1993 Jun;69(3):241-2. doi: 10.1136/sti.69.3.241-a.

Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.甲硝唑及其他硝基咪唑类药物的选择性毒性机制。

Br J Vener Dis. 1980 Oct;56(5):285-90. doi: 10.1136/sti.56.5.285.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验